CWColin H. Wilson

Colin H. Wilson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Colin H. Wilson has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Waitlist suspension is associated with persistent reduction in access to liver transplantation

    by Abdullah K. Malik, Lauren E. Matevish, Rhiannon Taylor, Samuel J. Tingle, Steven Masson, Colin H. Wilson, Steven A. White, Varuna Aluvihare, Madhukar S. Patel, Derek M. Manas

  • Open Access

    Machine perfusion modulates cold-preservation injury in kidney transplantation: IDEAL stage 4 United States population cohort study

    by Dharesh Raj Amarnath, Georgios Kourounis, Allan Massie, Dorry Segev, Ina Jochmans, Colin H. Wilson, Samuel J. Tingle


  • Open Access

    A Scoping Review of the Photographic Assessment of Donor Liver Steatosis in Transplantation Using Artificial Intelligence

    by Georgios Kourounis, Samuel J. Tingle, Ali Elmahmudi, Brian Thomson, Robin Nandi, Emily Thompson, Barney Stephenson, James Hunter, Hassan Ugail, Neil S. Sheerin, et al.

    Introduction: Accurate evaluation of liver steatosis and overall organ quality is critical for optimizing safe organ utilization in liver transplantation. Recent advances in computer vision offer promising tools to standardize and enhance this process. This review maps the current evidence on AI‐enabled photographic evaluation of liver steatosis and identifies areas for future development. Methods: A scoping review of the literature, including searches of PubMed, SCOPUS, and Web of Science, was conducted to identify studies published from inception to 27/03/2025 reporting on the development of AI‐enabled tools for assessing liver organ quality from photographs taken during the donation process. A qualitative synthesis and critical review of the literature was conducted in accordance with PRISMA‐ScR guidelines. The review protocol was registered with the Open Science Framework (osf.io/zfcuk). Results: After screening 219 citations, six studies from three independent research groups met the inclusion criteria. Sample sizes ranged from 40 to 192 donors. Five studies employed binary classification models using a 30% steatosis threshold, while one study reported a graded approach. Reported accuracies ranged from 0.81 to 0.92. Common challenges included small and imbalanced datasets with a dependence on supplementary donor data, such as blood tests and radiological findings. None of the studies conducted external validation. Discussion: Current evidence is drawn from a small and methodologically heterogeneous literature. Publications from several independent groups nevertheless highlight growing interest in developing these tools. Future work should prioritize larger studies with robust external validation to strengthen their credibility and build trust in their clinical use.


  • Open Access

    O6: EARLY ANASTOMOTIC BILIARY COMPLICATIONS AFTER LIVER TRANSPLANTATION

    by Sj Tingle, Er Thompson, Ss Ali, Ik Ibrahim, E Irwin, G Sen, Sa White, Dm Manas, Ch Wilson

    Introduction: Biliary leaks and anastomotic strictures are common early biliary complications (EBC) following liver transplantation. However, their impact on outcomes remains controversial and poorly described. Method: The NHS registry on adult liver transplantation between 2006 and 2017 was retrospectively reviewed (n=8304). Multiple imputations were performed to account for missing data. Adjusted regression models were used to assess predictors of EBC, and their impact on outcomes. 35 potential variables were included, and backwards stepwise selection enabled unbiased selection of variables for inclusion in final models. Result: EBC occurred in 9.6% of patients. Adjusted cox regression revealed that EBCs have a significant and independent impact on graft survival (Leak HR=1.325; P=0.021, Stricture HR=1.514; P=0.002, Leak plus stricture HR=1.533; P=0.034) and patient survival (Leak HR=1.218; P=0.131, Stricture HR=1.578; P<0.001, Leak plus stricture HR=1.507; P=0.044). Patients with EBC had longer median hospital stay (23 versus 15 days; P<0.001) and increased chance for readmission within the first year (56% versus 32%; P<0.001). On adjusted logistic regression the following were identified as independent risk factors for development of EBC: donation following circulatory death (OR=1.280; P=0.009), accessory hepatic artery (OR=1.324; P=0.005), vascular anastomosis time in minutes (OR=1.005; P=0.032) and ethnicity ‘other’ (OR=1.838; P=0.011). Conclusion: EBCs prolong hospital stay, increase readmission rates and are independent risk factors for diminished graft survival and increased mortality in liver transplantation. We have identified factors that increase the likelihood of EBC occurrence; further research into interventions to prevent EBCs in these at-risk groups is vital to improve liver transplantation outcomes. Take-home message: Using a large registry database we have shown that early anastomotic biliary complications are independent risk factors for decreased graft survival and increased mortality after liver transplantation. Research into interventions to prevent biliary complications in high risk groups are essential to improve liver transplant outcomes.

  • Open Access

    O59: USE OF DEXTRAN 40 FOLLOWING PANCREAS TRANSPLANT MAY REDUCE EARLY INFLAMMATION AND SIGNIFICANT BLEEDING COMPARED TO A HEPARIN-BASED PROTOCOL

    by Ah Innes, Sj Tingle, I Ibrahim, E Thompson, L Bates, D Manas, S White, C Wilson

    Introduction: Dextran 40 (D40) is a synthetic colloid with anticoagulant properties, which is commonly used instead of heparin following pancreas transplantation, however there is a lack of evidence over which is more effective. Graft thrombosis and pancreatitis, which may be mediated through micro or macrothrombosis within the graft, remain significant complications following pancreas transplantation. We hypothesised that D40 reduces inflammation through its antithrombotic pro-microcirculatory effects. We aimed to evaluate D40 compared to a heparin-based protocol by comparing post-operative complications and post-transplant levels of inflammation. Method: Data were collected retrospectively for pancreas transplant patients between December 2009 and August 2018 – 26 patients had been treated with the pre-Dextran protocol and 37 had received D40. Post-operative complications and inflammatory markers (WCC, CRP and amylase) on post-operative days 1, 2, 3 and 7 were compared between the two groups. Potential confounders were also recorded. Result: Patients in the D40 group had similar thrombosis rates but were less likely to have had substantial post-operative bleeding compared to the heparin-based protocol. The group who received D40 had significantly lower CRP and WCC on days 2, 3 and 7. The differences on days 3 and 7 remained when the results were adjusted for the significant confounders - cold ischaemic time and donor age. Conclusion: D40 appears to be as effective as IV heparin at preventing graft thrombosis following pancreas transplant, and to confer a reduced risk of bleeding. It may also reduce post-operative inflammatory processes, leading to reduced graft pancreatitis. Take-home message: Using Dextran 40 as an anticoagulant after pancreas transplantation is as effective as IV heparin at preventing graft thromboses and has a reduced risk of bleeding.

  • Open Access

    Cell therapy during machine perfusion

    by Emily R. Thompson, Chloe Connelly, Simi Ali, Neil S. Sheerin, Colin H. Wilson

    There has been increasing use of organs from extended criteria or donation after circulatory death donors to meet the demands of the transplant waiting list. Over the past decade, there has been considerable progress in technologies to preserve organs prior to transplantation to improve the function of these marginal organs. This has led to the development of normothermic machine perfusion, whereby an organ is perfused with warmed, oxygenated blood and nutrients to resume normal physiological function in an isolated ex vivo platform. With this advance in preservation comes significant opportunities to recondition, repair and regenerate organs prior to transplantation using cellular therapies. This review aims to discuss the possibilities of machine perfusion technology; highlighting the potential for organ directed reconditioning and the future avenues for investigation in this field.


  • Top Cited Papers

    Prehabilitation prior to surgery for pancreatic cancer: A systematic review

    by James R. Bundred, Sivesh K. Kamarajah, John S. Hammond, Colin H. Wilson, James Prentis, Sanjay Pandanaboyana


  • Time to reflect, time to move on

    by Emily R. Thompson, Colin H. Wilson

    Stenting the ureter during renal transplantation was a source of controversy for decades and Ooms et al have grappled with this topic again in this issue of Transplant International1. The team in Rotterdam have designed and implemented a research trial, after the first iteration of the Cochrane review on ureteric stents2, published back in 2005.

  • Open Access

    Expression of serine/threonine protein kinase SGK1F promotes an hepatoblast state in stem cells directed to differentiate into hepatocytes

    by Fouzeyyah Alsaeedi, Rachel Wilson, Charlotte Candlish, Ibrahim Ibrahim, Alistair C. Leitch, Tarek M. Abdelghany, Colin Wilson, Lyle Armstrong, Matthew C. Wright

    The rat pancreatic AR42J-B13 (B-13) cell line differentiates into non-replicative hepatocyte-like (B-13/H) cells in response to glucocorticoid. Since this response is dependent on an induction of serine/threonine protein kinase 1 (SGK1), this may suggest that a general pivotal role for SGK1 in hepatocyte maturation. To test this hypothesis, the effects of expressing adenoviral-encoded flag tagged human SGK1F (AdV-SGK1F) was examined at 3 stages of human induced pluripotent stem cell (iPSC) differentiation to hepatocytes. B-13 cells infected with AdV-SGK1F in the absence of glucocorticoid resulted in expression of flag tagged SGK1F protein; increases in β-catenin phosphorylation; decreases in Tcf/Lef transcriptional activity; expression of hepatocyte marker genes and conversion of B-13 cells to a cell phenotype near-similar to B-13/H cells. Given this demonstration of functionality, iPSCs directed to differentiate towards hepatocyte-like cells using a standard protocol of chemical inhibitors and mixtures of growth factors were additionally infected with AdV-SGK1F, either at an early time point during differentiation to endoderm; during endoderm differentiation to anterior definitive endoderm and hepatoblasts and once converted to hepatocyte-like cells. SGK1F expression had no effect on differentiation to endoderm, likely due to low levels of expression. However, expression of SGK1F in both iPSCs-derived endoderm and hepatocyte-like cells both resulted in promotion of cells to an hepatoblast phenotype. These data demonstrate that SGK1 expression promotes an hepatoblast phenotype rather than maturation of human iPSC towards a mature hepatocyte phenotype and suggest a transient role for Sgk1 in promoting an hepatoblast state in B-13 trans-differentiation to B-13/H cells.